Pallavi Mohapatra

Employment

• Memorial Sloan Kettering Cancer Center Research Fellow
  2023 - Present
• Institute of Life Sciences Research Scholar
  2018 - 2023

Education

• Institute of Life Sciences Ph.D.
  2018 - 2023
• Sambalpur University Masters in Life Sciences (Biochemistry specialization)
  2015 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Single-cell analysis identifies BASP1 as a driver of drug resistance and cell plasticity in oral squamous cell carcinoma.
  The Journal of biological chemistry 2026 DOI: 10.1016/j.jbc.2025.111126
  +Save
• NEK9-mediated Wnt signalling repressor TLE3 rewires Docetaxel resistance in cancer cells by inducing pyroptosis.
  British journal of cancer 2025 DOI: 10.1038/s41416-025-03148-5
  +Save
• CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis
  Oncogene 2022 DOI: 10.1038/s41388-022-02475-8
  +Save
• CMTM6 attenuates cisplatin-induced cell death in OSCC by regulating AKT/c-Myc-driven ribosome biogenesis
  The FASEB Journal 2022 DOI: 10.1096/fj.202200808rr
  +Save
• Correction: RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway
  British Journal of Cancer 2021 DOI: 10.1038/s41416-021-01414-w
  +Save
• The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy
  Frontiers in Oncology 2021 DOI: 10.3389/fonc.2020.612337
  +Save
• CMTM6 drives cisplatin resistance by regulating Wnt signaling through ENO-1/AKT/GSK3β axis
  JCI Insight 2021 DOI: 10.1172/jci.insight.143643
  +Save